Ongoing clinical trials and approved products targeting Collagen (fibrosis), in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| [68Ga]CBP8 (collagen)NCT05619302 · Cardiac amyloidosis | Phase 3 | Active, not recruiting | Brigham and Women's Hospital | 1 |
| [68Ga]CBP8 (collagen)NCT05417776 · Other | Phase 2 | Recruiting | Massachusetts General Hospital | 1 |
| [68Ga]CBP8 (collagen)NCT04485286 · Inflammatory diseases | Phase 2 | Recruiting | Massachusetts General Hospital | 1 |
| [68Ga]CBP8 (collagen)NCT06532071 · Inflammatory diseases | Phase 2 | Recruiting | Peter Caravan | 1 |
| [68Ga]CBP8 (collagen)NCT07572383 · Inflammatory diseases | Phase 2 | Recruiting | Peter Caravan | 1 |
| [68Ga]CBP8 (collagen)NCT03535545 · Inflammatory diseases | Phase 1 | Recruiting | Massachusetts General Hospital | 1 |
Collagen (fibrosis). Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/collagen-fibrosis/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.